Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-24T10:10:16.822Z Has data issue: false hasContentIssue false
  • English
  • Français

Constructing Unit-Specific Empiric Treatment Guidelines for Catheter-Related and Primary Bacteremia by Determining the Likelihood of Inadequate Therapy

Published online by Cambridge University Press:  02 January 2015

Megan E. Davis ,
Deverick J. Anderson ,
Michelle Sharpe ,
Luke F. Chen  and
Richard H. Drew
Megan E. Davis*
Affiliation:
Department of Pharmacy, Duke University Health System, Durham, North Carolina Department of Pharmacy, Sentara Virginia Beach General Hospital, Virginia Beach, Virginia
Deverick J. Anderson
Affiliation:
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
Michelle Sharpe
Affiliation:
Department of Pharmacy, Duke University Health System, Durham, North Carolina
Luke F. Chen
Affiliation:
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
Richard H. Drew
Affiliation:
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina Campbell University College of Pharmacy and Health Sciences, Buies Creek, North Carolina
*
Sentara Virginia Beach General Hospital, 1060 First Colonial Road, Virginia Beach, VA 23454 (medavis@sentara.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

This study aimed to determine the feasibility of using likelihood of inadequate therapy (LIT), a parameter calculated by using pathogen frequency and in vitro susceptibility for determination of appropriate empiric antibiotic therapy for primary bloodstream infections. Our study demonstrates that LIT may reveal differences in traditional antibiograms.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 33 , Issue 4: Special Topic Issue: Antimicrobial Stewardship , April 2012 , pp. 416 - 420
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Binkely, S, Fishman, NO, LaRosa, LA, et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol 2006;27:682–687.CrossRefGoogle Scholar
2. Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
3. Burgmann, H, Stoiser, B, Heinz, G, et al. Likelihood of inadequate treatment: a novel approach to evaluating drug-resistance patterns. Infect Control Hosp Epidemiol 2009;30(7):672–677.Google Scholar
4. Horan, C, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–392.CrossRefGoogle ScholarPubMed
5. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing—Eighteenth Informational Supplement. Wayne, PA: CLSI; 2008. CLSI document M100-S18.Google Scholar